Deciphera Pharmaceuticals Company
At Deciphera remains steadfast in mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which people live and work.
Headquarters:
United States
Industry:
Genomic and Epigenominc Instabillity
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Technology:
Small Molecules
Founded Date:
2003